Adding CBT to GLP-1 Drugs Further Cuts Heavy Drinking

The new finding

A summary of research from the National Institutes of Health reports that participants with alcohol use disorder who received a weekly GLP-1 receptor agonist combined with cognitive behavioral therapy (CBT) had larger reductions in heavy drinking days than participants who received either intervention alone. This sits on top of the Lancet trial from May 2 that established semaglutide 2.4mg weekly as superior to placebo for reducing heavy drinking in patients with AUD and comorbid obesity.

The headline is no longer that GLP-1s work. The headline is that they work more when paired with the behavioral therapy that AUD treatment has used as a standard of care for decades.

Why this matters

Alcohol use disorder affects roughly 28.9 million U.S. adults — by raw count, comparable to or larger than opioid use disorder, and dramatically more lethal in absolute deaths. It is also the category where pharmacotherapy uptake is lowest. FDA-approved medications for AUD (naltrexone, acamprosate, disulfiram) have remained underprescribed in primary care for two decades.

GLP-1 medications already have a primary-care prescribing infrastructure. If the combination effect holds in larger trials — and there are several Phase 3 studies underway, including a VA-led trial of semaglutide for AUD in veterans — the practical opening here is to treat AUD inside the same visit that already covers metabolic and weight management, with CBT delivered alongside. That is a different model from the one the field has been waiting on, and it is closer to where most patients with AUD actually receive care: a primary-care provider, not a specialty addiction practice.

For Rize, this reinforces something our V2 recommendation algorithm is already designed around — matching by what the person needs, not by where the legacy referral pathways send them. For alcohol seekers, that may increasingly mean primary care plus CBT, not specialty residential.

If you or someone you love is in crisis, call or text 988.